- Home
- PXS vs ALGS Comparison
PXS vs ALGS Comparison
Compare PXS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- ALGS
- Stock Information
- Founded
- PXS 2015
- ALGS 2018
- Country
- PXS Greece
- ALGS United States
- Employees
- PXS N/A
- ALGS N/A
- Industry
- PXS Marine Transportation
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- PXS Consumer Discretionary
- ALGS Health Care
- Exchange
- PXS Nasdaq
- ALGS Nasdaq
- Market Cap
- PXS 30.2M
- ALGS 36.0M
- IPO Year
- PXS N/A
- ALGS 2020
- Fundamental
- Price
- PXS $2.90
- ALGS $7.14
- Analyst Decision
- PXS Strong Buy
- ALGS Strong Buy
- Analyst Count
- PXS 1
- ALGS 1
- Target Price
- PXS $10.00
- ALGS $70.00
- AVG Volume (30 Days)
- PXS 54.3K
- ALGS 135.0K
- Earning Date
- PXS 08-11-2025
- ALGS 08-05-2025
- Dividend Yield
- PXS N/A
- ALGS N/A
- EPS Growth
- PXS N/A
- ALGS N/A
- EPS
- PXS 0.63
- ALGS N/A
- Revenue
- PXS $49,342,000.00
- ALGS $3,270,000.00
- Revenue This Year
- PXS N/A
- ALGS N/A
- Revenue Next Year
- PXS $31.36
- ALGS $51.55
- P/E Ratio
- PXS $4.58
- ALGS N/A
- Revenue Growth
- PXS 8.07
- ALGS N/A
- 52 Week Low
- PXS $2.53
- ALGS $3.76
- 52 Week High
- PXS $5.53
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- PXS 48.10
- ALGS 50.99
- Support Level
- PXS $2.78
- ALGS $7.11
- Resistance Level
- PXS $3.16
- ALGS $8.66
- Average True Range (ATR)
- PXS 0.15
- ALGS 0.88
- MACD
- PXS 0.01
- ALGS -0.02
- Stochastic Oscillator
- PXS 35.96
- ALGS 38.79
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.